Congress trades in AbbVie (ABBV)
17 of the members we track disclosed 33 purchases of ABBV between 2022-01-28 and 2026-03-27, and 40 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How ABBV was classified.
How these buys are tagged
AbbVie is a mega-cap, so a committee-aligned purchase here is tagged Aligned (Mega-cap) rather than Notable: owning a company this size says little about committee access. 22 are marked Cluster: A buy is marked Cluster when at least one other tracked member of Congress bought the same stock within 30 days of it, regardless of committee membership.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 33 | +2.0% | +2.1% | 64% |
| Notable (committee-flagged) | 0 | Too few buys to measure | ||
| Unaligned (no committee overlap) | 23 | +1.5% | +2.2% | 61% |
| Cluster, excl. mega-caps | 0 | Too few buys to measure | ||
| Not clustered, excl. mega-caps | 0 | Too few buys to measure | ||
Who bought the most
- Josh Gottheimer — 9 buys
- Lisa C. McClain — 3 buys
- Robert Bresnahan — 2 buys
- Julia Letlow — 2 buys
- Jared Moskowitz — 2 buys
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 2026-07-21 |
Aligned (Mega-cap) | $209.40 | -0.3% | -5.1% | +21.0% | +9.1% |
| Lisa C. McClain | 2025-10-30 2025-11-21 |
Unaligned | $228.20 | -4.0% | -0.2% | -3.4% | -10.0% |
| Lisa C. McClain | 2025-07-22 2025-08-13 |
Unaligned | $187.11 | +2.2% | +12.0% | +23.7% | +15.0% |
| Lisa C. McClain | 2025-06-17 2025-08-13 |
Unaligned Cluster | $185.48 | +0.0% | +3.2% | +16.6% | +14.0% |
| Josh Gottheimer | 2025-05-22 2025-06-11 |
Unaligned Cluster | $182.54 | +1.7% | +1.5% | +14.8% | +9.8% |
| Robert Bresnahan | 2025-05-15 2025-06-09 |
Unaligned Cluster | $181.68 | +0.5% | +5.2% | +12.7% | +10.0% |
| Julia Letlow | 2025-04-28 2026-01-13 |
Aligned (Mega-cap) Cluster | $192.34 | +1.9% | -4.8% | -2.0% | +0.4% |
| Jared Moskowitz | 2025-04-07 2025-05-09 |
Unaligned Cluster | $186.55 | -4.0% | +0.8% | +0.6% | +0.7% |
| Josh Gottheimer | 2025-04-03 2025-05-14 |
Unaligned Cluster | $201.64 | -13.6% | -1.6% | -6.1% | -0.8% |
| Josh Gottheimer | 2025-04-01 2025-05-14 |
Unaligned Cluster | $206.27 | -14.8% | -6.3% | -7.9% | -3.3% |
| Robert Bresnahan | 2025-02-25 2025-03-27 |
Unaligned Cluster | $204.14 | +1.8% | -0.7% | -9.0% | +2.2% |
| Jefferson Shreve | 2025-02-24 2025-03-09 |
Unaligned Cluster | $204.08 | +3.6% | -1.4% | -10.2% | +1.5% |
| Jared Moskowitz | 2025-01-15 2025-02-10 |
Unaligned | $171.35 | -1.3% | +12.6% | +0.2% | +3.2% |
| Virginia Foxx | 2024-12-06 2025-01-06 |
Unaligned | $176.19 | -1.6% | +2.9% | +21.6% | +18.2% |
| Julia Letlow | 2024-10-23 2026-01-13 |
Aligned (Mega-cap) Cluster | $187.88 | +7.2% | -5.8% | -9.9% | -4.5% |
| Ritchie Torres | 2024-09-26 2025-08-20 |
Unaligned Cluster | $191.90 | +1.8% | -2.1% | -6.6% | +2.2% |
| John James | 2023-11-10 2024-09-02 |
Aligned (Mega-cap) Cluster | $138.59 | -0.2% | +7.7% | +25.6% | +11.6% |
| Tommy Tuberville | 2023-10-17 2023-11-16 |
Aligned (Mega-cap) Cluster | $149.18 | -1.9% | -7.3% | +8.2% | +1.6% |
| Greg Stanton | 2023-09-26 2023-11-09 |
Unaligned Cluster | $153.91 | -4.2% | -5.7% | +0.5% | -3.8% |
| Lois Frankel | 2023-09-06 2023-10-10 |
Aligned (Mega-cap) Cluster | $145.61 | +3.8% | +1.8% | +0.5% | +0.1% |
| Lois Frankel | 2023-08-30 2023-10-10 |
Aligned (Mega-cap) Cluster | $148.32 | -1.8% | +0.5% | -6.6% | -2.8% |
| Michael Guest | 2023-08-07 2023-08-23 |
Aligned (Mega-cap) Cluster | $150.33 | +1.3% | -3.1% | -6.1% | -1.8% |
| Dan Goldman | 2023-03-07 2023-04-17 |
Unaligned Cluster | $152.93 | +0.6% | +5.6% | -11.4% | -13.5% |
| Josh Gottheimer | 2023-03-06 2023-04-20 |
Unaligned Cluster | $155.28 | -2.1% | +3.6% | -11.9% | -13.2% |
| Dan Goldman | 2023-01-31 2023-02-24 |
Unaligned | $147.75 | -1.8% | +4.5% | +2.6% | +2.4% |
| Dwight Evans | 2022-08-05 2022-08-19 |
Aligned (Mega-cap) | $138.04 | +3.3% | -1.3% | +5.2% | +5.7% |
| Robert J. Wittman | 2022-06-16 2022-07-08 |
Unaligned | $139.15 | +7.4% | +10.4% | +2.4% | -4.1% |
| Tommy Tuberville | 2022-03-30 2022-04-08 |
Aligned (Mega-cap) Cluster | $163.75 | +3.2% | -10.3% | -5.9% | +1.2% |
| Josh Gottheimer | 2022-03-17 2022-04-17 |
Unaligned Cluster | $158.59 | +1.1% | +2.3% | -12.3% | -0.4% |
| Josh Gottheimer | 2022-03-08 2022-04-17 |
Unaligned Cluster | $147.15 | +5.9% | +17.8% | +1.4% | -1.8% |
| Josh Gottheimer | 2022-02-18 2022-03-18 |
Unaligned | $144.03 | +3.8% | +10.5% | +4.8% | +3.1% |
| Josh Gottheimer | 2022-02-09 2022-03-18 |
Unaligned | $143.20 | +1.9% | +4.1% | +6.1% | +12.2% |
| Josh Gottheimer | 2022-01-28 2022-02-18 |
Unaligned | $137.92 | +2.0% | +8.4% | +6.5% | +6.6% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 40 disclosed sales of ABBV are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in ABBV are a small part of the full rankings, which score each member across everything they bought.
Data last updated .